Shannon-Lowe C - Search Results

1

A novel antiviral formulation inhibits a range of enveloped viruses.

Fletcher NF, Meredith LW, Tidswell EL, Bryden SR, Gonçalves-Carneiro D, Chaudhry Y, Shannon-Lowe C, Folan MA, Lefteri DA, Pingen M, Bailey D, McKimmie CS, Baird AW. Fletcher NF, et al. Among authors: shannon lowe c. J Gen Virol. 2020 Oct;101(10):1090-1102. doi: 10.1099/jgv.0.001472. J Gen Virol. 2020. PMID: 32692647 Free article.

2

Defective infectious particles and rare packaged genomes produced by cells carrying terminal-repeat-negative epstein-barr virus.

Feederle R, Shannon-Lowe C, Baldwin G, Delecluse HJ. Feederle R, et al. J Virol. 2005 Jun;79(12):7641-7. doi: 10.1128/JVI.79.12.7641-7647.2005. J Virol. 2005. PMID: 15919916 Free PMC article.

3

Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth.

Shannon-Lowe C, Baldwin G, Feederle R, Bell A, Rickinson A, Delecluse HJ. Shannon-Lowe C, et al. J Gen Virol. 2005 Nov;86(Pt 11):3009-3019. doi: 10.1099/vir.0.81153-0. J Gen Virol. 2005. PMID: 16227222

4

Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.

Tierney R, Nagra J, Hutchings I, Shannon-Lowe C, Altmann M, Hammerschmidt W, Rickinson A, Bell A. Tierney R, et al. J Virol. 2007 Sep;81(18):10092-100. doi: 10.1128/JVI.00358-07. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626071 Free PMC article.

5

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.

Shannon-Lowe C, Adland E, Bell AI, Delecluse HJ, Rickinson AB, Rowe M. Shannon-Lowe C, et al. J Virol. 2009 Aug;83(15):7749-60. doi: 10.1128/JVI.00108-09. Epub 2009 May 13. J Virol. 2009. PMID: 19439479 Free PMC article.

6

Epstein Barr virus entry; kissing and conjugation.

Shannon-Lowe C, Rowe M. Shannon-Lowe C, et al. Curr Opin Virol. 2014 Feb;4:78-84. doi: 10.1016/j.coviro.2013.12.001. Epub 2014 Feb 16. Curr Opin Virol. 2014. PMID: 24553068 Review.

7

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.

Rowe M, Raithatha S, Shannon-Lowe C. Rowe M, et al. J Virol. 2014 Oct;88(20):12065-76. doi: 10.1128/JVI.01431-14. Epub 2014 Aug 13. J Virol. 2014. PMID: 25122803 Free PMC article.

8

Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.

Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M. Tierney RJ, et al. Virology. 2015 Jan 1;474:117-30. doi: 10.1016/j.virol.2014.10.030. Epub 2014 Nov 15. Virology. 2015. PMID: 25463610 Free PMC article.

9

The Epstein-Barr virus and the pathogenesis of lymphoma.

Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. Vockerodt M, et al. J Pathol. 2015 Jan;235(2):312-22. doi: 10.1002/path.4459. J Pathol. 2015. PMID: 25294567 Review.

10

Epstein-Barr virus-associated lymphomas.

Shannon-Lowe C, Rickinson AB, Bell AI. Shannon-Lowe C, et al. Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):20160271. doi: 10.1098/rstb.2016.0271. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28893938 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page